Desogestrel And Ethinyl Estradiol Kit
Product Images NDC 31722-540

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Desogestrel And Ethinyl Estradiol (NDC 31722-540). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Camber Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Desogeeblistercard (Desogeeblistercard)

Blister card packaging for Desogestrel and Ethinyl Estradiol Tablets USP 0.15 mg/0.03 mg by Camber Pharmaceuticals, Inc. The kit contains 28 tablets arranged in a 4-week, 7-day per week format with circular push-through compartments. The first three weeks have white to off-white tablets, and the fourth week has green tablets. The label includes manufacturing and contact information, storage instructions, and a barcode.*

FDA Label Image

Desogeecartonlabel (Desogeecartonlabel)

Packaging label for Desogestrel and Ethinyl Estradiol Tablets, USP 0.15 mg/0.03 mg kit by Camber Pharmaceuticals, Inc. The label indicates 3 pouches, each containing 28 tablets for a 28-day regimen. It includes dosage form as tablets and usage information, with manufacturer details for Camber Pharmaceuticals and Amora Pharma Pvt. Ltd.*

FDA Label Image

Desogeefig1 (Desogeefig1)

A bar graph showing mortality rates (number of deaths per 100,000 woman-years) across different age groups (15-24, 25-34, 35-44, 45+) comparing ever-users (smokers and non-smokers) and controls (smokers and non-smokers). Mortality rates increase significantly with age, with ever-user smokers showing the highest mortality rates in the 45+ age group.*

FDA Label Image

Desogeefig2 (Desogeefig2)

A forest plot chart showing effect estimates (odds ratios or relative risks) from multiple studies related to Desogestrel and Ethinyl Estradiol use. The studies include NICHD Women's Contraceptive Study (2002), French E3N cohort Study (2005), Shanghai Womens Health Study (2009), The Nurses' Health Study II (2010), Oxford Family Planning Association Study (2013), and Danish Sex Hormone Register Study (2017) for both ever and current use, with effect estimates and confidence intervals plotted on a horizontal axis labeled from -1.5 to 2.*

FDA Label Image

Desogeelogo (Desogeelogo)

FDA Label Image

Desogeepouchlabel (Desogeepouchlabel)

Desogestrel and Ethinyl Estradiol Tablets, USP 0.15 mg/0.03 mg kit by Camber Pharmaceuticals, Inc., labeled with NDC 31722-540-32. The kit contains a 28-day regimen blister card of 28 tablets. The front label includes storage instructions, dosage info, and coloring additive details. The back label highlights product name, strength, and usage notice.*

FDA Label Image

Desogeestru (Desogeestru)

Chemical structure diagrams of Desogestrel and Ethinyl Estradiol. The image shows the molecular formulas C22H30O and C20H24O2 with their respective molecular weights 310.48 and 296.4 beneath each structure.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.